This work is supported by the Cancer Center Clinical Trials Unit, dedicated clinic space and infusion centers, inpatient unit, a new cGMP and TCT laboratory, FACT accredited TCT program in pediatric autologous and allogeneic BMT and immune effector cell therapy, fully characterized tumor samples repository and new state-of-the-art Children Hospital building opened in 2021, all on the Medical School campus. Successful candidate will have a primarily clinical assignment, but will also be expected to develop, conduct, and participate in clinical trials, other collaborative research in blood and marrow transplantation, and cellular immunotherapy.